Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ATAI Life Sciences NV ATAI

Healthcare
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B... see more

Bullboard (NDAQ:ATAI)

View:
Post by whytestockson Apr 09, 2024 7:00pm

Missouri to Use $10M from Opioid Funds to Study Psilocybin

News; $ATAI Missouri to Use $10M from Opioid Funds to Study PsilocybinLegislators in the House of Representatives in the state of Missouri have awarded preliminary approval to a budget measure that ...more  
25
Post by StockJunkie4994on May 08, 2023 11:49am

Top 5 Shroom Stocks

https://thedalesreport.com/psychedelics/tdrs-top-5-psychedelic-developments-for-the-week-of-may-1/
127
Post by Karylleon Apr 13, 2023 4:10am

Kevin Harrington Discusses FSD Pharma

I believe this new product will aid society in reducing the ...more  
64
Post by Karylleon Jun 03, 2022 5:29am

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of ...more  
87
Post by Karylleon Apr 18, 2022 2:40am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings ...more  
220
Post by Karylleon Apr 09, 2022 12:55pm

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ...more  
95
Post by Karylleon Apr 07, 2022 1:05pm

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to ...more  
74
Post by AwareInvestoron Jun 18, 2021 7:54am

Atai Life Sciences Increases IPO To $225 Million

Atai Life Sciences late last night announced the pricing of its upsized initial public offering. The clinical-stage biotech firm now expects its IPO to raise gross proceeds of roughly $225.0 million ...more  
167